New York State Common Retirement Fund Rapt Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Rapt Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 11,549 shares of RAPT stock, worth $14,089. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,549
Previous 11,549
-0.0%
Holding current value
$14,089
Previous $23,000
21.74%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RAPT
# of Institutions
100Shares Held
124MCall Options Held
246KPut Options Held
69.6K-
Medicxi Ventures Management (Jersey) LTD22.4MShares$27.3 Million7.76% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA13.1MShares$16 Million3.39% of portfolio
-
Orbimed Advisors LLC San Diego, CA13.1MShares$16 Million0.56% of portfolio
-
Foresite Capital Management Vi LLC Larkspur, CA12.5MShares$15.3 Million8.8% of portfolio
-
Rtw Investments, LP New York, NY11.8MShares$14.4 Million0.3% of portfolio
About RAPT Therapeutics, Inc.
- Ticker RAPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,656,600
- Market Cap $36.2M
- Description
- RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that se...